Enfrentando la enfermedad de Alzheimer en los países en desarrollo.
Rev Neuropsiquiatr 80 (2), 2017 (P. 105-110)
Recibido: 03/02/2017 Aceptado: 12/06/2017
Last updated on Oct 5, 2018.
EMCDDA Insights - 11
Accessed: 14.03.2019
mhGAP is based on evidence-based technical guidelines (4) and provides a set of tools and
training packages to extend service provision. The mhGAP Intervention Guide (mhGAP-IG)
for MNS disorders in non-specialized health settings (8) is a clinical decision-making tool
for assessing and managing p...riority MNS conditions (depression, psychoses, epilepsy, child
and adolescent mental and behavioural disorders, dementia, disorders due to substance
use, self-harm and suicide).
more
A workshop methodology for children, young people and adults
The “Tree of Life” is a psychosocial support tool based on narrative practices that is designed to help participants accept the hardships of their past and identify the strengths that can help them achieve a better future. It uses th...e different parts of a tree as metaphors to represent the different parts of our lives. The workshop generally takes one day.
Participants draw their own “Tree of Life” in which they get to speak of their ‘roots” (where they come from), their skills and knowledge, their hopes and dreams and the special people in their lives
more
Alcohol, medication, tobacco, illegal drugs, addictive behaviour
Second, revised edition with new layout
Juni 2014
Harm reduction: evidence, impacts and challenges
-10-
Advocacy ,Social Mobilization ,Behavior Change Communications
Harm Reducation, Decriminalization and Zero Discrimination for People who use Drugs
Introduction
Chapter A.4
2017 edition
This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws o...f their country of practice. Some medications may not be available in some countries and readers should consult the specific drug information since not all the unwanted effects of medications are mentioned.
more
Externalising disorders
Chapter D.3
Mood disorders
Chapter E.1
2015 edition
Anxiety disorders
Chapter F.2
Anxiety disorders
Chapter F.3
Other disorders Chapter H.1
Other disorders
Chapter H.5.1